Rheumatoid Arthritis Stem Cell Therapy Market

Rheumatoid arthritis stem cell therapy has been demonstrated to induce profound healing activity, halt arthritic conditions, and in many cases, reverse and regenerate joint tissue. Today, bone marrow transplant, adipose or fat-derived stem cells, and allogeneic mesenchymal stem cells (human umbilical cord tissue) are used for rheumatoid arthritis stem cell therapy. As the rheumatoid arthritis worsens, the body initiates autoimmune response and attacks the cells. Rheumatoid arthritis stem cell therapy is growing in popularity across hospitals, ambulatory surgical centers, and specialty clinics, as it increases the healing of joints and further treats the entire system that causes the joint pain and inflammation.
Rheumatoid Arthritis Stem Cell Therapy Market contains market size and forecasts of Rheumatoid Arthritis Stem Cell Therapy in Global, including the following market information:
Global Rheumatoid Arthritis Stem Cell Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Rheumatoid Arthritis Stem Cell Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Allogeneic Mesenchymal Stem Cells Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Rheumatoid Arthritis Stem Cell Therapy include Mesoblast, Roslin Cells, Regeneus, ReNeuron Group, International Stem Cell Corporation and Takeda, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Rheumatoid Arthritis Stem Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rheumatoid Arthritis Stem Cell Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Rheumatoid Arthritis Stem Cell Therapy Market Segment Percentages, by Type, 2021 (%)
Allogeneic Mesenchymal Stem Cells
Bone Marrow Transplant
Adipose Tissue Stem Cells
Global Rheumatoid Arthritis Stem Cell Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Rheumatoid Arthritis Stem Cell Therapy Market Segment Percentages, by Application, 2021 (%)
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Global Rheumatoid Arthritis Stem Cell Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Rheumatoid Arthritis Stem Cell Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rheumatoid Arthritis Stem Cell Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Rheumatoid Arthritis Stem Cell Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mesoblast
Roslin Cells
Regeneus
ReNeuron Group
International Stem Cell Corporation
Takeda